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Article
Targeting of early endosomes by autophagy
facilitates EGFR recycling and signalling
Jane Fraser1, Joanne Simpson1, Rosa Fontana1, Chieko Kishi-Itakura2, Nicholas T Ktistakis2 &
Noor Gammoh1,*
Abstract
Despite recently uncovered connections between autophagy and
the endocytic pathway, the role of autophagy in regulating endo-
somal function remains incompletely understood. Here, we find
that the ablation of autophagy-essential players disrupts EGF-
induced endocytic trafficking of EGFR. Cells lacking ATG7 or
ATG16L1 exhibit increased levels of phosphatidylinositol-3-phos-
phate (PI(3)P), a key determinant of early endosome maturation.
Increased PI(3)P levels are associated with an accumulation of
EEA1-positive endosomes where EGFR trafficking is stalled. Aber-
rant early endosomes are recognised by the autophagy machinery
in a TBK1- and Gal8-dependent manner and are delivered to
LAMP2-positive lysosomes. Preventing this homeostatic regulation
of early endosomes by autophagy reduces EGFR recycling to the
plasma membrane and compromises downstream signalling and
cell survival. Our findings uncover a novel role for the autophagy
machinery in maintaining early endosome function and growth
factor sensing.
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Introduction
Vesicular trafficking processes are important in controlling various
aspects of cell fate decisions and homeostasis. Of these processes,
both endocytosis and autophagy are known to deliver cellular
cargoes to lysosomes for degradation and are involved in relaying
cues from the extracellular milieu. Recent studies have begun to
uncover mechanisms through which the endocytic and autophagic
compartments can act in concert to facilitate their optimal activities.
Endocytosis begins with the internalisation of plasma
membrane cargoes into early, or “sorting”, endosomes marked by
specific adaptor proteins and small Rab GTPases [1–3]. These
vesicles can then mature into endosomes destined for various
cellular compartments including the plasma membrane (recycling
endosomes) or lysosomes (late endosomes), thereby regulating the
activities of endocytic cargoes such as receptor tyrosine kinases
(RTKs) [4]. Efficient signalling from a subset of endocytosed RTKs
has been shown to utilise autophagy-related membranes as signal-
ling platforms [5–7], suggesting that autophagy proteins can regu-
late pro-growth signalling independent of their degradative
function. This is of particular interest given that the perturbed
activities of many RTKs, including the epidermal growth factor
receptor (EGFR), have been associated with various cancers and
developmental defects [8–11].
Autophagy-mediated degradation of various cellular components
is critical to maintain cellular homeostasis [12]. Recently, autop-
hagy has been shown to target damaged lysosomal membranes
and bacteria-containing vesicles, suggesting that it can mediate the
degradation of these vesicles [13–15]. Such endomembrane
damage is recognised by the Galectin family of proteins that bind
glycans on the luminal face of the vesicles [15,16]. Tank-binding
kinase 1 (TBK1) is then required to recruit autophagy players,
including WIPI2 and ATG16L1, to the damage site where they
facilitate the ubiquitin-like conjugation of ATG8 paralogues, such
as LC3, to phosphatidylethanolamine and subsequently autophago-
some biogenesis [16,17]. While the role of LC3 in cargo recogni-
tion by binding to receptor proteins has been well studied,
increasing evidence suggests that upstream autophagy players can
also play an important role in recruiting autophagosome substrates
[18,19].
Autophagy and the endocytic pathway share multiple commonal-
ities [20]. For example, phosphoinositide-3-phosphate (PI(3)P) is
essential for the proper function of both early endosomes and
autophagosomes [3,21–23]. Its biogenesis from phosphoinositol is
mediated by vacuolar protein sorting-associated protein 34 (VPS34),
also known as phosphoinositide-3-kinase class III (PIK3C3) [24].
VPS34 can generate PI(3)P on either endocytic or autophagic
membranes by existing in two distinct complexes: the “autophagic”
complex I (comprised of ATG14, Beclin-1 and VPS15) and the
“endocytic” complex II (comprised of UVRAG, Beclin-1 and VPS15)
[25–28]. These complexes can be regulated by the availability of
growth factors and nutrients [29–31]. The endocytic pathway can
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also contribute to autophagosome biogenesis as a number of autop-
hagy players (such as ATG16L1, ATG9, WIPI2 and ULK1) can loca-
lise to Rab11-positive (Rab11+) recycling endosomes [32–34].
Furthermore, endocytic regulators (e.g. VAMP3, Rab7, CHMP2A
and STX17) have been found to be required for autophagosome
maturation, closure and their eventual fusion with lysosomes
[35–38]. While extensive studies highlight the contribution of the
endocytic pathway to autophagosome formation [20], less is known
on how autophagy is required for the optimal function of endosomes.
Here, we uncover a novel role for autophagy in maintaining
endosomal homeostasis by recognising and targeting perturbed
early endosomes. A consequence of inhibiting this process is the
disruption of EGFR endocytic sorting which impacts overall cellular
response to growth factor signalling.
Results
Loss of autophagy perturbs EGFR endocytic trafficking
Given the close interplay between endocytic and autophagic vesic-
ular trafficking, we were interested to understand how the loss of
autophagy can impact the endocytic pathway. To test this, we used
EGFR as a model endocytic cargo as its regulation has been exten-
sively studied [39]. Glial cells transformed by Ink4a/Arf deletion as
well as Tp53 and Nf-1 knockdown (shNf-1/shTp53) were used as a
model system [40,41], and CRISPR/Cas9-mediated gene editing of
autophagy-related genes (denoted as sgAtg) was introduced to
inhibit autophagy (Fig EV1). To observe the overall endocytic traf-
ficking of EGFR in real time, Alexa 555-labelled EGF (555-EGF)
was monitored in cells by live spinning disc confocal microscopy.
Tracking the paths of these vesicles revealed that while EGF exhib-
ited a dynamic trafficking pattern in control cells, it accumulated
in the perinuclear region of Atg7 knockout cells (Fig 1A).
Immunofluorescence staining of EGFR confirmed its perinuclear
accumulation in the absence of ATG7 after 15 min of EGF treat-
ment (Fig 1B and C). To further investigate this disrupted endo-
cytic trafficking, we assessed changes in ligand–receptor
colocalisation [42] and observed an increased percentage of EGFR
vesicles that remained positive for 555-EGF in autophagy-deficient
cells (Fig 1D and E). This elevated ligand–receptor binding is
suggestive of a perturbed trafficking of EGFR at early endosomes.
To test this, we assessed the colocalisation between EGFR and the
early endosome marker Rab5. Figure 1F and G shows that at early
time points (5 min), EGFR occupancy in Rab5+ endosomes was
comparable between control and sgAtg7 cells, indicating that early
endocytic uptake of EGFR from the plasma membrane is not
affected by ATG7 loss. However, at a later time point (15 min),
EGFR residency in early endosomes was strikingly increased in
sgAtg7 cells compared to control cells. Overall, these data suggest
that autophagy inhibition alters EGFR trafficking resulting in its
accumulation at early endosomes.
Autophagy inhibition increases PI(3)P-positive early endosomes
To further investigate a potential defect in early endosomes upon
autophagy deficiency, we examined the levels of PI(3)P, a key phos-
phoinositide determinant of autophagosome biogenesis and early
endosome function [2,43]. To do this, we employed a post-fixation
technique using an Alexa 488-conjugated recombinant FYVE-
domain probe in order to avoid interference with endosomal traf-
ficking as a result of PI(3)P-binding domain overexpression in cells
[44]. Interestingly, inhibition of autophagy in glial cells by ATG7 or
ATG16L1 deletion (Fig EV2A) resulted in increased overall cellular
levels of PI(3)P (Figs 2A and B, and EV2B). We further tested
whether this increase in PI(3)P levels was associated with early
endosomes marked by the PI(3)P effector EEA1 [2] and observed a
significant increase in PI(3)P+ EEA1 vesicles in sgAtg7 and
sgAtg16l1 glial cells (Fig 2A and C). Similar results were obtained in
sgAtg7 mouse embryonic fibroblasts (MEFs), suggesting that
changes in early endosomal PI(3)P as a result of autophagy inhibi-
tion are consistent in other cell types (Fig EV2C and D). As observed
with Rab5 (Fig 1F and G), EGFR exhibited a higher residency in
EEA1+ endosomes upon autophagy inhibition in glial cells (Fig 2D
and E).
The production of PI(3)P catalysed by VPS34 is regulated by
adaptor proteins that form part of the endocytic or autophagic
VPS34 complexes [25–28]. To test whether changes in PI(3)P levels
upon autophagy inhibition were due to differences in the binding of
VPS34 to its adaptor proteins, immunoprecipitations of endogenous
VPS34, or its binding partner Beclin-1, were performed from control
or sgAtg7 cells. The interactions between VPS34 and its complex
components, including Beclin-1, Rubicon, UVRAG and ATG14, were
unaltered by autophagy status (Figs 2F and G, and EV2E). Similar
results were obtained in MEF cells (Fig EV2F). Together, these find-
ings suggest that the compositions of VPS34 complexes are not
altered upon the deletion of autophagy genes.
Early endosomes are disrupted in the absence of autophagy
machinery and stain positively for Gal8
To further examine the cause of EGFR accumulation at Rab5+ and
EEA1+ endosomes, we tested the possibility that damaged early
endosomes accumulated in cells that lack autophagy. Recognition of
damaged endomembranes can be mediated by a family of glycan-
binding proteins known as Galectins that act as “eat-me” signals
[45]. Of these, Gal3, Gal8 and Gal9 have been involved in the recog-
nition of damaged lysosomes and salmonella-containing vesicles
[13–15]. To assess whether autophagy-deficient cells accumulate
damaged early endosomes that may be recognised by these Galec-
tins, we expressed YFP-tagged Gal3, Gal8 or Gal9 in glial cells and
their colocalisation with EEA1 was compared between control and
sgAtg7 cells. Figure 3A and B shows that while the colocalisation
between EEA1 and Gal3 or Gal9 was not significantly affected by
ATG7 depletion, Gal8 localisation to early endosomes was strongly
increased upon ATG7 loss. This suggests that damaged early endo-
somes may accumulate when autophagosome maturation is inhib-
ited by ATG7 deletion. Moreover, Gal8 labelled EGF+ vesicles in
ATG7-deficient cells, indicating that EGFR can localise to this subset
of damaged early endosomes (Fig 3C and D). Disruption of early
endosomal function can also be induced chemically by monensin
treatment in control glial cells resulting in enhanced localisation of
Gal8 at early endosomes (Fig 3E and F) [46]. Together, these data
suggest that damaged early endosomes can accumulate in the
absence of autophagy genes or during chemical disruption of
endomembranes.
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Autophagy machinery targets early endosomes
We hypothesised that damaged early endosomes may be recognised
by the autophagy machinery facilitating their targeting to the lyso-
some system. We tested this during monensin-induced endosomal
damage in autophagy-competent cells. Indeed, monensin treatment
resulted in the labelling of EEA1+ endosomes with GFP-LC3 stably
expressed in control glial or MEF cells but not in those lacking
ATG7 (Figs 4A and B, and EV3A and B). The localisation of LC3 to
EEA1+ vesicles suggests that the autophagy machinery may be
required to recruit lysosomes to early endosomes. Indeed, EEA1+
vesicles stained positive for the lysosomal marker LAMP2 following
monensin-induced endomembrane stress in control but not sgAtg7
cells (Fig 4C and D). Interestingly, treatment of cells with bafilo-
mycin A1 to inhibit lysosomal acidification led to the enhanced colo-
calisation between LC3 and EEA1, suggesting that the lysosomal
targeting of early endosomes by the autophagy machinery occurs
under basal levels (Fig 4A and B). A potential increase in total early
endosome number was not significant between autophagy-compe-
tent and autophagy-incompetent cells (Fig EV3C) likely due to high
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Figure 1. Loss of autophagy perturbs EGFR endocytic trafficking.
The following experiments were performed in glial shNf-1/shTp53 glial cells serum starved for 4 h before assaying. Cells were expressing either Cas9 alone (control) or Cas9
and sgRNA targeting Atg7 (sgAtg7 #1 or #2).
A Spinning disc confocal live cell imaging of Alexa 555-EGF (555-EGF) shown as vesicle tracking with time represented as a colour spectrum. Tracking started 5 min after
addition of 20 ng/ml 555-EGF for the indicated durations. Scale bar: 10 lm.
B Immunofluorescence staining of EGFR following 5- or 15-min stimulation with 20 ng/ml EGF. Scale bar: 20 lm.
C Quantification of EGFR vesicles in a perinuclear region (within 30 lm diameter of the centre of the nucleus) (in B).
D Cells were stimulated with 20 ng/ml 555-EGF for 15 or 30 min before immunofluorescence staining against EGFR. Scale bar: 10 lm.
E Quantification of percentage of total EGFR vesicles that colocalise with 555-EGF (in D).
F Cells stably expressing mCherry-Rab5 were stimulated with 20 ng/ml EGF for indicated times before immunofluorescence staining against EGFR. Scale bar: 10 lm.
G Pearson’s colocalisation coefficient between mCherry-Rab5 and EGFR (in F).
Data information: Statistical analyses were performed on at least three independent experiments, where error bars represent SEM and P values represent a two-tailed
Student’s t-test: NS P > 0.05, *P < 0.05, **P < 0.01.
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variations in endosome numbers between cells or the existence of
compensatory mechanisms that affect endosome biogenesis or
maturation. Altogether, these findings suggest that targeting of early
endosomes to lysosomes requires components of the autophagy
machinery.
We further interrogated the recruitment of upstream autophagy
players to early endosomes. Staining of EEA1 showed no significant
colocalisation with endogenous ATG16L1 in autophagy-competent
glial cells (Fig 4E and F) consistent with previously published find-
ings [47]. Similarly, induction of autophagy by amino acid starva-
tion did not enhance the colocalisation of EEA1 and ATG16L1 in
control cells (Fig EV3D). Intriguingly, a marked increase in the
colocalisation between endogenous ATG16L1 and a subset of
EEA1+ early endosomes was observed in ATG7-deficient glial cells
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Figure 2. Autophagy inhibition increases PI(3)P-Positive early endosomes.
The following experiments were performed in glial shNf-1/shTp53 glial cells serum starved for 4 h before assaying.
A Control, sgAtg7 or sgAtg16l1 cells were treated with 2 ng/ml EGF for 15 min. Cells were then processed for staining using anti-EEA1 antibodies and PI(3)P probe
(Alexa 488-labelled 2XFYVE domains). To ensure the specificity of the probe, control cells were pre-treated with 5 mM 3’MA for 30 min. Scale bar: 10 lm.
B Quantification of PI(3)P+ label intensity per cell (in A).
C Pearson’s colocalisation coefficient between PI(3)P and EEA1 (in A).
D Control and sgAtg7 cells were stimulated 20 ng/ml EGF for 5 or 15 min before immunofluorescence staining against EEA1 and EGFR. Scale bar: 10 lm.
E Pearson’s colocalisation coefficient between EEA1 and EGFR (in D).
F Endogenous VPS34 was immunoprecipitated from control and sgAtg7 cells that were treated with 2 ng/ml EGF for 15 min and then lysed in CHAPS-containing
detergent buffer and binding partners detected by Western blotting.
G Densitometry analyses of proteins coimmunoprecipitated with endogenous VPS34 (in F).
Data information: Statistical analyses were performed on at least three independent experiments, where error bars represent SEM and P values represent a two-tailed
Student’s t-test: NS P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001.
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(Fig 4E and F). This was also observed with Flag-S-tagged
ATG16L1 (Fig EV3E and F), demonstrating that both endogenous
and stably expressed ATG16L1 show comparable localisation [48].
Enhanced colocalisation between ATG16L1 and EEA1 was also
observed upon chemically induced endomembrane damage trig-
gered by monensin or Dynasore treatment [46,49,50] (Fig 4G and
H). This recruitment is less than that observed in ATG7-deficient
cells potentially due to the transient localisation of early autophagy
machinery during autophagosome maturation, which is arrested by
ATG7 deletion [51]. Importantly, structured illumination micro-
scopy revealed that ATG16L1 localised to a subpopulation of
EEA1+ early endosomes that were also positive for EGF in either
sgAtg7- or monensin-treated cells (Fig 4I and J), suggesting that
upstream autophagy players can recognise damaged early endo-
somes where EGFR is arrested.
We explored the possibility that the autophagy machinery may
be recruited to early endosomes through an LC3-associated phago-
cytosis (LAP)-like process which occurs on single membranes
requiring the core autophagy machinery (such as ATG7 and
ATG16L1) but not PI(3)P, WIPI2 or components of the ULK1
complex [52]. Assessment of endogenous WIPI2 localisation
revealed its positive staining on EEA1+ endosomes in sgAtg7 cells
(Fig 4K and L). In addition, a mutant of ATG16L1 that cannot
support non-canonical LC3 lipidation on single membranes
(ATG16L1K490A) [52] was also recruited to EEA1+ endosomes in
glial cells deficient for ATG7 (Fig EV3E and F) or MEFs lacking
endogenous ATG16L1 (Fig EV3G and H) further excluding a LAP-
like event. Moreover, the association between ATG16L1 and EEA1
was not observed in MEF cells lacking ATG13 (a component of the
ULK1 complex required for canonical autophagy but not LAP-like
A
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Figure 3. Early endosomes stain positively for Gal8 upon autophagy inhibition or monensin treatment.
The following experiments were performed in glial shNf-1/shTp53 glial cells serum starved for 4 h before assaying. Cells were expressing either Cas9 alone (control) or Cas9
and sgRNA targeting Atg7 (sgAtg7 #1 or #2).
A Cells transiently expressing YFP-Galectins (YFP-Gal3, YFP-Gal8, or YFP-Gal9) were stimulated with 2 ng/ml EGF for 15 min before fixation and immunofluorescence
staining against EEA1. Scale bar: 10 lm.
B Quantification of percentage of total EEA1 vesicles that colocalise with YFP-Galectins (in A).
C Cells transiently expressing YFP-Gal8 were stimulated with 20 ng/ml Alexa 555-EGF (555-EGF) for 15 min. Scale bar: 10 lm.
D Quantification of the percentage of YFP-Gal8-labelled vesicles that colocalise with 555-EGF in control or ATG7-deficient cells (in C).
E Cells transiently expressing YFP-Gal8 were treated 100 lM monensin for 1 h and stimulated with 2 ng/ml EGF for 15 min before fixation and immunofluorescence
staining against EEA1. Scale bar: 10 lm.
F Quantification of percentage of total EEA1 vesicles that colocalise with YFP-Gal8 upon monensin treatment (in E).
Data information: White arrows indicate colocalisation. Statistical analyses were performed on at least three independent experiments, where error bars represent SEM
and P values represent a two-tailed Student’s t-test: NS P > 0.05, **P < 0.01, ***P < 0.001.
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LC3 lipidation) (Fig EV3I and J) [53]. Finally, the addition of bafilo-
mycin A1, which inhibits the membrane recruitment of LC3 during
LAP-like processes [54], did not influence the localisation of GFP-
LC3 to early endosomes during monensin treatment (Fig 4A and B).
Altogether, these findings uncover a novel process of early endoso-
mal targeting by the canonical autophagy pathway.
Targeting of early endosomes by the autophagy machinery
requires TBK1 activity and Gal8
Previous studies have shown that clearance of damaged endomem-
branes, as well as selective forms of autophagy, requires the activity
of the TBK1 kinase, which phosphorylates autophagic receptors
[15,55]. To test whether TBK1 also plays a role during the recogni-
tion of damaged early endosomes by autophagy, costaining of active
phosphorylated TBK1 (p-TBK1) and EEA1 was performed. EEA1
vesicles stained positively for p-TBK1 in ATG7-deficient cells (Fig 5A
and B). Furthermore, treatment with the TBK1 inhibitors MRT68601
[56] and momelotinib [57] ablated EEA1-ATG16L1 colocalisation in
sgAtg7- and monensin-treated control cells (Fig 5C and D). These
findings therefore suggest that TBK1 activity lies upstream of the
recruitment of autophagy machinery to damaged early endosomes.
Having observed that damaged early endosomes are recognised
by Gal8, we further examined whether the recruitment of the autop-
hagy machinery to early endosomes required Gal8 expression. To
do so, we ablated Gal8 expression by CRISPR/Cas9 (Fig 5E) and
treated cells with monensin to induce endosome damage. As can be
seen in Fig 5F and G, knockout of Gal8 disrupted the colocalisation
between ATG16L1 and EEA1 during monensin treatment, suggesting
that Gal8 is required for the recognition of damaged early endo-
somes by the autophagy machinery.
Autophagy loss disrupts Rab11-mediated recycling of EGFR
We then investigated the consequences of EGFR accumulation in
early endosomes during autophagy inhibition. Labelling of cells
with fluorescent EGF showed that sgAtg7 cells exhibited an overall
decrease in EGF signal (Figs 6A and B, and EV4A and B), despite
the observed increase in EGF and EGFR colocalisation in autophagy-
deficient cells compared to their control counterparts (Fig 1D and
E). Reduced EGF staining was not due to perturbed lysosomal func-
tion [58] (Fig EV4C) or altered EGFR degradation rate (Fig EV4D
and E) consistent with the lack of change in EGFR-late endosome
colocalisation in the absence of autophagy (Fig EV4F and G). These
data indicate that late endosome-to-lysosome trafficking axis is not
affected by autophagy loss. Similarly, cell surface protein biotinyla-
tion experiments (outlined in Fig EV4H) showed no change in EGFR
endocytosis rate in sgAtg7 or sgAtg16l1 cells (Fig 6C) in agreement
with comparable EGFR-Rab5/EEA1 colocalisation at early time
points of EGF stimulation (Figs 1F and 2D). On the other hand, EGF
chase experiments revealed that the recycling of EGFR to the plasma
membrane was reduced upon the deletion of autophagy genes
(Fig 6D). This defective recycling of EGFR reduces receptor avail-
ability at the plasma membrane, which, coupled with intact receptor
degradation, can lead to diminished intracellular levels of EGF at
later time points in autophagy-deficient cells (Fig 6A). Interestingly,
EGFR recycling was also reduced in the presence of the endosome
damaging agent, monensin, when calculated as a percentage from
endocytosed population (Fig 6D). Monensin treatment also
perturbed EGFR endocytosis (Fig 6C) likely due to additional effects
of this inhibitor. To mimic the recycling defect caused by autophagy
loss, EGFRvIII was expressed in glial cells. This oncogenic mutant of
EGFR lacks the EGF-binding domain but can heterodimerise with
the full-length receptor, thereby altering its endocytic trafficking and
increasing downstream signalling [8]. EGFRvIII expression reduced
the endocytic trafficking of full-length EGFR (Fig 6C), as previously
described [8], and prevented its recycling in control cells to a similar
extent as loss of ATG7 or ATG16L1 (Fig 6D).
To characterise the disruption of EGFR recycling in the absence
of autophagy, we assessed EGFR colocalisation with the recycling
endosome markers Rab4 and Rab11. Although the colocalisation of
EGFR with Rab4 was not affected by autophagy inhibition
◀ Figure 4. Autophagy machinery targets early endosomes.The following experiments were performed in glial shNf-1/shTp53 glial cells serum starved for 4 h before assaying. Cells were expressing either Cas9 alone (control) or Cas9
and sgRNA targeting Atg7 (sgAtg7 #1 or #2).
A Cells stably expressing GFP-LC3 were treated with 100 lM monensin in the presence or absence of bafilomycin A1 (20 nM) for 1 h and stimulated with 2 ng/ml EGF
for 15 min before fixation and immunofluorescence staining against EEA1. White arrows indicate colocalisation. Scale bar: 10 lm.
B Quantification of percentage of total EEA1 vesicles that colocalise with GFP-LC3 (in A).
C Cells were treated for 1 h with 100 lM monensin and then stimulated with 2 ng/ml EGF for 15 min. LAMP2 and EEA1 were then detected by immunofluorescence
staining. White arrows indicate colocalisation. Scale bar: 10 lm.
D Quantification of the percentage of total EEA1 vesicles that colocalise with LAMP2 (in C).
E Cells were treated with 2 ng/ml EGF for 15 min before immunofluorescence against endogenous ATG16L1 and EEA1. Scale bar: 10 lm.
F Quantification of percentage of total EEA1 puncta that colocalise with ATG16L1 (in E).
G Cells stably expressing Flag-S-ATG16L1 were treated for 1 h with either 100 lM monensin or 30 lM Dynasore, and then stimulated with 2 ng/ml EGF for 15 min.
Cells were then stained by immunofluorescence against EEA1 and Flag tag. Scale bar: 10 lm.
H Quantification of percentage of total EEA1 vesicles that colocalise with Flag-S-ATG16L1 (in G).
I Untreated control or sgAtg7 cells, or control cells pre-treated with 100 lM monensin 1 h, stably expressing Flag-S-ATG16L1 were stimulated 20 ng/ml Alexa 555-EGF
(555-EGF) for 15 min before fixation and immunofluorescence staining against Flag tag and EEA1. Cells were then imaged by structured illumination microscopy
(SIM), and images were reconstructed in Nikon Elements software. Scale bar: 10 lm.
J Quantification of the percentage of EGF-EEA1 colocalised vesicles that stained triple-positive with ATG16L1 by SIM (in I). Due to the low-throughput nature of this
assay, the following cell numbers were counted: control untreated (9 cells), sgAtg7#1 (10 cells), sgAtg7#2 (9 cells) and control + monensin (11 cells).
K Cells were treated with 2 ng/ml EGF for 15 min before immunofluorescence against endogenous WIPI2 and EEA1. Scale bar: 10 lm.
L Quantification of percentage of total EEA1 puncta that colocalise with WIPI2 (in K).
Data information: White arrows indicate colocalisation. Statistical analyses were performed on at least three independent experiments, where error bars represent SEM
and P values represent a two-tailed Student’s t-test: *P < 0.05, **P < 0.01, ***P < 0.001.
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Figure 5. TBK1 and Gal8 are required for the recruitment of autophagy machinery to early endosomes.
The following experiments were performed in glial shNf-1/shTp53 glial cells serum starved for 4 h before assaying. Cells were expressing either Cas9 alone (control) or Cas9
and sgRNA targeting Atg7 (sgAtg7 #1 or #2).
A Cells were treated for 15 min with 2 ng/ml EGF before fixation and immunofluorescence staining against EEA1 and p-TBK1. White arrows indicate colocalisation.
Scale bar: 10 lm.
B Quantification of percentage of total EEA1 vesicles that colocalise with p-TBK1 (in A).
C Cells stably expressing Flag-S-ATG16L1 were pre-treated for 1 h with TBK1 inhibitors (100 lM MRT68601 or 5 lM momelotinib). Control cells were also treated
100 lM monensin for 1 h as indicated. All cells were stimulated for 15 min with 2 ng/ml EGF followed by fixation and immunofluorescence staining against Flag tag
and EEA1. Scale bar: 10 lm.
D Quantification of total EEA1 vesicles that colocalise with Flag-S-ATG16L1 (in C).
E Western blotting of shNf-1/shTp53 glial cells expressing gRNA sequences targeting Gal8.
F Control and sgGal8 cells stably expressing Flag-S-ATG16L1 were treated 100 lM monensin for 1 h and stimulated with 2 ng/ml EGF for 15 min before fixation and
immunofluorescence staining against EEA1 and Flag tag. White arrows indicate colocalisation. Scale bar: 10 lm.
G Quantification of percentage of total EEA1 vesicles that colocalise with Flag-S-ATG16L1 in sgGal8 cells (in F).
Data information: Statistical analyses were performed on at least three independent experiments, where error bars represent SEM and P values represent a two-tailed
Student’s t-test: *P < 0.05, **P < 0.01, ***P < 0.001.
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(Fig EV4I and J), its colocalisation with Rab11 was markedly
reduced (Fig 6E and F). This reduced recycling of EGFR in the
absence of autophagy was not associated with a general defect in
recycling endosomes as assessed by the recycling rate of the trans-
ferrin receptor, which was not affected by ATG7 loss (Fig EV4K
and L). Together, these data indicate that autophagy is required for
the efficient endocytic recycling of EGFR to the plasma membrane
via Rab11 recycling endosomes.
Autophagy is required for the maintenance of EGF-mediated
signalling and survival
The recycling of RTKs to the plasma membrane is important for the
maintenance of their signalling activities [4]. To test the impact of
reduced EGFR recycling upon autophagy inhibition, we assessed
receptor activation and downstream signalling pathways during
EGF stimulation in glial cells. Cells lacking the core canonical autop-
hagy players, including ATG7, ATG16L1, ATG3, ATG13 or the cargo
recognition protein Gal8, exhibited reduced EGF-induced phospho-
rylation of EGFR, AKT and ERK (Figs 7A–C and EV5A and B).
Importantly, no significant differences in signalling were observed
at early time points of EGF stimulation in ATG7-deficient cells,
supporting our findings that the initial activation and endocytosis of
EGFR were not affected by autophagy loss (Fig 7D and E). Expres-
sion of the endocytosis-defective EGFRvIII mutant that enhances
downstream signalling [59] restored EGF-mediated AKT phosphory-
lation in sgAtg7 cells, thereby suggesting that altering the intracellu-
lar trafficking of EGFR can overcome the signalling defect caused by
A B
D
FE
C
Figure 6. Autophagy loss disrupts Rab11-mediated recycling of EGFR.
A Glial shNf-1/shTp53 control and sgAtg7 cells were serum starved for 4 h and then stimulated with 20 ng/ml Texas Red-EGF (TxRed-EGF) for 30 min. Scale bar: 10 lm.
B Quantification of TxRed-EGF puncta per cell, relative to the number taken up by control cells (in A).
C Endocytosis rate of wild-type (WT) EGFR was assayed in control, sgAtg7 or sgAtg16l1 glial shNf-1/shTp53 or EGFRvIII-expressing cells by cell surface biotinylation and
one application of 2 ng/ml EGF for 15 min. Monensin treatment was added as indicated.
D Plasma membrane recycling rate of WT EGFR in control, sgAtg7 or sgAtg16l1 glial shNf-1/shTp53 or EGFRvIII-expressing cells was assayed by cell surface biotinylation
and successive applications of 2 ng/ml EGF treatments for 15 min (detailed in Fig EV4H). Monensin treatment was added as indicated.
E Glial shNf-1/shTp53 control and sgAtg7 cells stably overexpressing mCherry-Rab11 were serum starved for 4 h, then stimulated with 20 ng/ml EGF for 15 min, and
then fixed and stained by immunofluorescence against EGFR. White arrows indicate colocalisation. Scale bar: 10 lm.
F Quantification of Pearson’s colocalisation coefficient between mCherry-Rab11 and EGFR (in E).
Data information: Statistical analyses were performed on at least three independent experiments, where error bars represent SEM and P values represent a two-tailed
Student’s t-test: NS P > 0.05, *P < 0.05, ***P < 0.001.
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A B
D
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G
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Figure 7. Autophagy is required for the maintenance of EGF-mediated signalling and survival.
A–C Glial shNf-1/shTp53 sgAtg7 (A), sgAtg16l1 (B) or sgGal8 (C) cells were either left untreated (+serum) or serum starved (serum) for 4 h and then stimulated 2 ng/ml
EGF for 15 min before analyses by Western blotting.
D Glial shNf-1/shTp53 control and sgAtg7 cells were serum starved for 4 h and then stimulated with 2 ng/ml EGF for the indicated times before analysis of EGFR
signalling pathway activity by Western blotting.
E Phosphorylated:total protein ratios for EGFR and AKT calculated from densitometry analyses of Western blots were made relative to their respective points of
maximal stimulation (100%) (for EGFR: t = 5 min in control cells and for AKT: t = 7 min in control cells) (in D).
F Glial shNf-1/shTp53 control and sgAtg7 cells were serum starved for 4 h with or without 20 ng/ml EGF 30-min stimulation before subcellular fractionation and
analysis by Western blotting.
G Radar chart indicating the relative levels of pAKT (pink line), pEGFR (light blue line) or total EGFR levels (dark blue line), in autophagy-deficient cell lines relative to
their control counterparts. The following knockouts were introduced: glial cells (sgAtg7), HT29 (crATG7), MCF-7 (sgATG5), A549 (sgATG5), U2OS (sgATG5) and MEFs
(Atg16l1/).
H Control or sgAtg7 glial shNf-1/shTp53 cells were serum starved for 24 h in the presence or absence of 20 ng/ml EGF. Quantification of the percentage of propidium
iodide (PI)-positive cells is shown.
Data information: Statistical analyses were performed on at least three independent experiments, where error bars represent SEM and P values represent a two-tailed
Student’s t-test: NS P > 0.05, *P < 0.05, **P < 0.01.
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ATG7 loss (Fig EV5C). In addition, EGF-induced nuclear transloca-
tion of EGFR, which is required for its role as a co-transcriptional
activator for pro-growth and survival genes [60], was also reduced
by autophagy loss (Fig 7F). Together, these data support the conclu-
sion that the targeting of early endosomes by the autophagy machin-
ery is required for proper cellular responses to EGF stimulation.
Having observed similar early endosome defects in MEFs upon
autophagy inhibition, we tested EGF-mediated signalling in these
cells. Intriguingly, AKT and ERK phosphorylation during EGF stim-
ulation were comparable in autophagy-deficient Atg16l1/ MEFs
and those reconstituted with wild-type ATG16L1 (ATG16L1WT,
Fig EV5D). However, EGFR protein levels appeared to rely on
functional autophagy in MEFs as total EGFR levels were elevated
by the expression of ATG16L1WT in Atg16l1/ cells but not by an
autophagy-deficient mutant that cannot bind ATG5 (ATG16L1DA5)
[61,62]. Similar reduction in EGFR levels was also observed in
autophagy-deficient MEFs lacking ATG7 or ATG3 (Fig EV5E) and
are likely due to reduced EGFR plasma membrane localisation that
may decrease its stability in the absence of acute EGF stimulation.
These observations indicate that the disruption of endosomal
homeostasis as a result of autophagy inhibition may impact the
EGFR pathway in a cell-type-specific manner. To further investi-
gate this, we tested cellular response to EGF stimulation in a panel
of cell lines genetically engineered to inhibit autophagy (Fig EV5F–
I). As can be seen in Fig 7G, autophagy inhibition led to a striking
perturbation in EGFR phosphorylation or total levels in the major-
ity of lines tested. This suggests that targeting of endosomes by
autophagy can affect EGFR trafficking and activation in a panel of
cell lines. On the other hand, the downstream Akt activation in
response to EGF stimulation differed between the cell lines tested.
This variation in signalling response to growth factor stimulation is
likely dependent on additional oncogenic mutations that enhance
pro-growth signalling.
To test whether reduced EGFR signalling in the absence of autop-
hagy impacted EGF-mediated cell survival, glial cells were starved
of growth factors (serum starvation) in the presence or absence of
EGF and cell death was measured by propidium iodide staining.
Figures 7H and EV5J and K show that while serum starvation-
induced cell death can be rescued in control cells by the addition of
EGF, survival of ATG7-deficient cells remained unaltered, mirroring
their inability to maintain pro-growth signalling. Reduced EGF-
mediated cell survival in sgAtg7 cells was rescued by the expression
of EGFRvIII, thereby indicating that rescuing the signalling defect in
autophagy-deficient cells can prevent the onset of cell death
(Fig EV5J and K). Taken together, these data demonstrate that qual-
ity control of early endosomes by autophagy is important for EGFR
trafficking, pro-growth signalling and cell survival.
Discussion
The results presented here outline a novel role for autophagy in
regulating early endosome homeostasis. In the absence of autop-
hagy, damaged or non-functional early endosomes accumulate
EGFR and inhibit its recycling back to the plasma membrane. This
results in the perturbation of EGF-mediated signalling and survival
and underlies a novel mechanism by which autophagy can regulate
RTK signalling.
Ligand binding stimulates the activation of RTKs leading to their
internalisation via clathrin-dependent or clathrin-independent
means [63]. While the former is favoured by low doses of growth
factors (such as those used in this study) and primarily results in
receptor recycling to the plasma membrane, higher doses largely
engage clathrin-independent endocytosis machinery and direct the
receptor to the lysosome [4]. After their internalisation, active RTKs
occupy pre-early endosomes that are negative for PI(3)P. Production
of PI(3)P following the recruitment of the endosome-specific VPS34
complex II represses RTK signalling [3]. Our study suggests that
autophagy inhibition can reduce EGF-mediated signalling by
prolonging the residence of EGFR on PI(3)P+ early endosomes.
Whether the overall increase in PI(3)P levels upon autophagy inhi-
bition have additional consequences in the cell is yet to be deter-
mined.
Autophagy inhibition also suppresses EGF-mediated signalling
by reducing receptor recycling. Our data demonstrate that EGFR is
arrested at early endosomes that fail to mature into Rab11+ recy-
cling endosomes, while trafficking to Rab7+ or Rab4+ endosomes
remain intact. Interestingly, autophagy knockdown does not appear
to interfere with transferrin receptor recycling thereby suggesting an
additional degree of cargo or endosomal population specificity. The
mechanisms mediating the maturation of early to recycling endo-
somes are not fully understood, although it is known that phospho-
inositol and Rab switching are required [64,65]. Previous studies
comparing the internalisation of EGF and transferrin show that each
cargo was incorporated at distinct sites with EGF being associated
with vesicles enriched with EEA1 [66,67]. This suggests that autop-
hagy inhibition may affect a subset of early endosomes, where EGFR
is localised, that are destined to mature into Rab11+ recycling endo-
somes. The precise mechanism through which this occurs remains
unknown and is suggestive of the existence of unknown regulatory
mechanisms governing endosome maturation. As autophagy
appears to affect a subset of membrane receptors rather than general
recycling, its inhibition may serve as a useful tool to decipher such
mechanisms.
Previous studies suggest that ATG16L1 can traffic from the
plasma membrane via clathrin-coated pits to recycling endosomes
without intermediately localising to early endosomes [33,34,68]. In
support of this, our data indicate that the colocalisation between
ATG16L1 and early endosomes occurs at low levels and is only
augmented upon autophagy inhibition or treatment with endosomal
damaging agents. It may be that ATG16L1 traffics through early
endosomes en route from the plasma membrane to recycling endo-
somes but is arrested in early endosomes when damage is recog-
nised. This transient or lack of localisation between ATG16L1 and
early endosomes under normal conditions could be important to
prevent unwanted degradation of functional early endosomes. How
early endosomes can be marked for degradation while recycling
endosomes contribute to autophagosome biogenesis is yet to be
elucidated.
The specific recruitment of Gal8, but not Gal3 or Gal9, to aber-
rant early endosomes suggests that these Galectins may differen-
tially recognise a binding partner on the damaged endomembrane.
Interestingly, out of these three Galectins, only Gal8 has been shown
to bind the mTOR apparatus during lysosome injury [14]. Further-
more, studies have shown that although the carbohydrate recogni-
tion domain of Galectins is structurally similar, they differ
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considerably in their amino acid compositions potentially leading to
the recognition of specific carbohydrate moieties on damaged endo-
somes by Gal8 but not by other Galectins [69,70]. The precise signal
that facilitates the recruitment of Gal8 to damaged early endosomes
and the subsequent events that lead to the activation of the autop-
hagy machinery remain to be elucidated.
The recruitment of LAMP2+ lysosomes to perturbed early endo-
somes in an autophagy-dependent manner is suggestive of an
“endosome-phagy” process. Our findings thereby contribute to an
expanding picture of organelle homeostasis mediated by autophagy.
The selective degradation of ER, mitochondria and ribosomes has
been shown to be critical for a variety of cellular processes [71,72].
Targeting of early endosomes by autophagy relies on the recognition
of damaged membranes by Gal8- and TBK1-mediated signalling, in
a similar mechanism to the clearance of damaged lysosomes or
bacteria-containing vesicles [14–16]. We find that the accumulation
of damaged early endosomal membranes perturbs EGFR trafficking.
Localisation of autophagy proteins to endosomes has also been
observed during amphisome formation as well as during direct lipi-
dation of LC3 on single membranes [73, 74]. Whether these
phenomena also contribute to the requirement of autophagy
proteins in the proper trafficking of EGFR remains to be determined.
Interestingly, EGFR knockout animals have neurological phenotypes
that resemble autophagy loss [75,76]. Additionally, pro-growth
signalling pathways downstream of EGFR, which are known to be
key drivers of oncogenesis, have been shown to be reduced in
autophagy-deficient tumour models [10,41,77]. Altered RTK traf-
ficking upon autophagy ablation may contribute to these defects.
Therefore, it would be interesting to test whether additional plasma
membrane endocytic cargoes are also affected by the lack of autop-
hagy. Such mechanisms may provide novel means by which the
homeostatic role of autophagy impacts important physiological and
pathological processes such as in development, immunity and
cancer.
Materials and Methods
Cell culture, generation and treatment
The following cell lines were maintained at 37°C and 5% CO2 in
Dulbecco’s modified Eagle’s media (DMEM) supplemented with 10
units/ml penicillin, 100 lg/ml streptomycin, 2 mM L-glutamine and
10% foetal bovine serum (FBS) (all reagents were manufactured by
Thermo Fisher Scientific): XFM/tv-a glial cells expressing the avian
virus receptor, TV-A, and harbouring a deletion in the Ink4a/Arf
locus [40,41], DF-1 chicken fibroblasts (ATCC, CRL-12203), mouse
embryonic fibroblasts (MEFs), human embryonic kidney cells
(293T), A549 adenocarcinoma cells (WT and DATG5, kind gift from
Dr Simon Wilkinson, University of Edinburgh) [78], U2OS osteosar-
coma cells, MCF-7 breast cancer cells, Atg16l1/ MEFs (kind gift
from Dr Shizuo Akira, Osaka University) [79] and Atg13/ MEFs.
HT29 colorectal cancer cells were maintained at 37°C and 5%
CO2 in McCoy’s 5A medium supplemented with 10 units/ml peni-
cillin, 100 lg/ml streptomycin, 2 mM L-glutamine and 10% FBS (all
Thermo Fisher Scientific).
293T cells were used to generate retroviral particles by transfec-
tion with polyethylenimine-based lipopolyplexes. For generation of
RCAS viruses, DF-1 cells were transfected with the respective RCAS
vectors using Lipofectamine 2000 (Thermo Fisher Scientific) accord-
ing to the manufacturer’s instructions. Following several passages,
DF-1 supernatants containing RCAS viruses were collected and used
for 3 rounds of infection in XFM/tv-a glial cells. All viruses were fil-
tered and used to infect cells in the presence of 1 lg/ml polybrene
(Millipore). Gene expression was tested by Western blotting to con-
firm enhanced or reduced protein levels. Importantly, pooled glial
cells were assayed within 10 passages and were not freeze-thawed.
To genetically inhibit autophagy in the array of cell lines tested
in Figs 7 and EV5, several methods were required. Atg3 and Atg7
knockout MEFs were generated by CRISPR/Cas9-mediated gene
editing using Lipofectamine 2000-mediated transient transfection of
Cas9 and gRNA constructs, and pooled cells were confirmed by
Western blotting. crRNA/tracRNA complexes targeting ATG7
sequences (Dharmacon, CM-020112-01-0005) were introduced using
DharmaFECT 2 Transfection Reagent (Dharmacon) in Cas9-expres-
sing HT29 cells according to the manufacturer’s instructions. For
glial cells, MEFs and HT29 cells, CRISPR/Cas9 knockout lines were
generated by multiple rounds of transfection/infection (usually up
to 3 rounds) in the absence of any antibiotics treatment, FACS sort-
ing or single-cell clone selection, and successful inhibition of autop-
hagy was confirmed by Western blotting. Conversely, ATG5
knockout MCF-7 and U2OS cell lines stably expressing Cas9 were
generated by infection with lentiviral vectors expressing sgRNA
targeting ATG5 sequences followed by puromycin selection (Milli-
pore).
All EGF and transferrin stimulations were preceded by 4-h incu-
bation in serum-free DMEM. EGF was used at 2 ng/ml or 20 ng/ml
(as indicated in the figure legends), and fluorescently labelled EGF
was used at 20 ng/ml. While lower concentrations of EGF favour
receptor recycling and higher concentrations trigger lysosomal
degradation [4], the observed effects of autophagy inhibition on the
endocytic system were found to be independent of EGF concentra-
tions.
For amino acid starvation, cells were incubated in amino acid-
free DMEM for 4 h.
The following inhibitors were used: Dynasore (30 lM, Sigma),
monensin (100 lM, Sigma), bafilomycin A1 (20 nM, Cell Signaling
Technologies), momelotinib (5 lM, Selleck Chemicals) and
MRT68601 (100 lM, Tocris).
Plasmids
For expression in XFM/tv-a glial cells, the following plasmids were
used: lentiCas9-Blast (gift from Feng Zhang, Addgene plasmid
#52962), RCAS-Y vector (gift from William Pavan, Addgene
#11478), MSCV-EGFRvIII (gift from Alonzo Ross, Addgene #20737),
YFP-Galectin-3, YFP-Galectin-8 or YFP-Galectin-9 (kind gifts from
Felix Randow: Thurston et al, 2012), mCherry-Rab4 (gift from
Michael Davidson, Addgene #55125), mCherry-Rab5 and mCherry-
Rab11 (gift from Michael Davidson, Addgene #55124).
For the generation of the RCAS-shRNA vectors, shRNA
sequences were initially cloned into pSUPER.retro vectors (OligoEn-
gine, VEC-PRT-0002) [41]. The shRNA and H1 promoter sequences
were then amplified by PCR and cloned into RCAS-Y vectors using
NotI and PacI restriction sites. The shRNA target sequences are as
follows: RCAS-shNf-1 (50 CAAGGAGTGTCTGATCAAC), RCAS-shTp
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53 (50 GTACATGTGTAATAGCTCC) and RCAS-shAtg13 (50 GAGAA
GAATGTCCGAGAAT).
For CRISPR/Cas9-mediated gene editing using RCAS-Y vectors,
sgRNA sequences were cloned into sgRNA-expressing vectors (gift
from George Church, Addgene #41824) as previously described
[80]. The sgRNA and U6 promoter sequences were then amplified
by PCR and cloned into RCAS-Y vectors using NotI restriction site.
The following sgRNA targeting sequences were used: sgAtg3 #1 (50
ATGTGATCAACACGGTGAA, sgAtg3 #2 (50 GTTTACACCGCTTGTA
GCA), sgAtg7 #1 (50 TCACAGGTCCCCGGATTAG), sgAtg7 #2 (50 GA
AACTTGTTGAGGAGCAT), sgAtg16l1 #1 (50 CGAACTGCACAAGAA
GCGT), sgAtg16l1 #2 (50 AAAGCATGACATGCCAAAT), sgGal8 #1
(50 AGGCGTTGTCCTGTTGTTT) and sgGal8 #2 (50 GGCTGCCTGCTT
CACATAC). RCAS vectors expressing sgRNA sequences were
infected into XFM/tv-a glial cells expressing lentiCas9. Control cells
were generated expressing lentiCas9 alone and mock infected with
DF-1 media.
For CRISPR/Cas9-mediated gene editing in MEFs, the sgRNA
vectors described above (Addgene #41824) were transfected along a
Cas9 vector (hCas9, gift from George Church, Addgene #41815)
using Lipofectamine 2000. Control cells were generated expressing
Cas9 alone and empty gRNA vector.
For CRISPR/Cas9-mediated gene editing in MCF-7 and U2OS
cells, lentiGuide-puro lentivirus was used to target ATG5 (50 GAGA
TATGGTTTGAATATGA).
Plasmids expressing retroviral pBabe-Flag-S-ATG16L1WT, pBabe-
Flag-S-ATG16L1DA5 (deletion of Atg5-binding domain, residues
1-39) and pBabe-GFP-LC3 were described previously [61]. pBabe-
Flag-S-ATG16L1K490A mutant was a kind gift from Oliver Florey
(University of Cambridge) [52].
Cell lysis, Western blotting and immunoprecipitation
For cell lysate analyses, cells were washed twice in ice-cold PBS
before lysis in RIPA buffer (10 mM Tris pH 7.5, 100 mM NaCl,
1 mM EDTA, 1 mM EGTA, 0.1% SDS, 1% Triton X-100, 1 mM
b-ME, 0.5% sodium deoxycholate and 10% glycerol) supple-
mented with fresh protease inhibitor cocktail V and phosphatase
inhibitors (Fisher Scientific, UK). Lysates were cleared by spin-
ning at 21,000 g for 10 min at 4°C. SDS loading buffer (200 mM
Tris pH 6.8, 8% SDS, 40% glycerol, 4% b-mercaptoethanol) was
diluted 1:4 into lysates. Following 5-min incubation at 95°C,
lysates were separated by SDS–PAGE and then transferred onto
nitrocellulose membranes (Bio-Rad). Membranes were blocked
with 5% non-fat milk TBST before probing with primary antibod-
ies at room temperature for 2–4 h or at 4°C overnight. Following
washes in TBST, membranes were then incubated with HRP-
conjugated secondary antibodies for 1 h at RT in milk/TBST and
developed under UV light using ClarityTM Western ECL substrate
(Bio-Rad, 1705061). Western blotting densitometry analysis was
performed in ImageLab (Bio-Rad). The radar chart of pAKT,
pEGFR and total EGFR ratios comparing ATG knockout to control
cells (Fig 7G) was generated from densitometry quantifications of
3 independent experiments for each cell line (representative blots
in Fig EV5).
For immunoprecipitations, cells were lysed in buffer containing
either 0.8% CHAPS or 0.5% NP-40 and 150 mM NaCl, 25 mM
HEPES pH 7.5, 1 mM b-mercaptoethanol, 0.2 mM CaCl2 and
0.5 mM MgCl2 supplemented with fresh phosphatase and protease
inhibitors and the proteasome inhibitor MG132 (50 lM, Sigma).
Cell fractionation
To obtain cytosolic, membrane and nuclear fractions, cells were
serum starved for 4 h and then stimulated with 20 ng/ml EGF for
30 min. Cells were then scrapped in an isotonic buffer (150 mM
NaCl, 25 mM HEPES pH 7.5, 1 mM b-mercaptoethanol, 0.2 mM
CaCl2 and 0.5 mM MgCl2) supplemented with fresh phosphatase
and protease inhibitors. For cytosolic fraction isolation, 1 lg/ml
digitonin (Sigma) was added and lysates incubated for 30 min at
4°C before spinning for 1 min at 15,000 g. The resulting pellet was
washed three times with the isotonic buffer and then resuspended
in isotonic buffer containing 0.5% NP-40 (Source BioScience).
Lysates were then vortexed and spun at 15,000 g for 1 min. The
resulting pellet containing the nuclear fraction was similarly washed
and resuspended in SDS loading buffer diluted 1:4 in RIPA buffer
followed by mechanical sheering using a syringe. The various cell
fractions were then analysed by SDS–PAGE and Western blotting.
Antibodies
Antibodies against the following targets were used for either Western
blotting (WB) or immunofluorescence (IF) as indicated:
b-actin (WB: Sigma, A5316), AKT (WB: CST, 9272), pSer473-AKT
(WB: CST, 4060), ATG3 (WB: MBL, M133-3), ATG7 (WB: Sigma,
A2856), ATG13 (WB: Sigma, SAR4200100), ATG5 (WB: Sigma,
A0731), ATG14 (WB: MBL, PD026), ATG16L1 (WB and IF: MBL,
PD040), ATG16L1 (WB: MBL, M150-3), Beclin-1 (WB: MBL, PD017),
EEA1 (IF: CST, 3288), EEA1 (IF: BD Biosciences, 410456), EGFR (WB
and IF: Santa Cruz, sc-03), EGFR (WB: Millipore, 04-290), pTyr1068-
EGFR (WB: CST, 2234), ERK (WB: CST, 9102), pThr202/pTyr204-
ERK (WB: CST, 4370), FIP200 (IF: Abcam, ab176816), Galectin-3
(WB: Santa Cruz, sc-32790), Galectin-8 (WB: Abcam, ab109519), b1-
Integrin (WB: CST, 4706), LAMP2 (IF: Abcam, ab25631), LC3B (WB:
Sigma, L7543), NF-1 (WB: Bethyl Labs, A300-140A), PCAF (WB:
Santa Cruz, E-08), VPS34/PIK3C3 (WB: CST, 4263), Rab5 (WB and
IF: CST, 3547), Rab7 (IF: CST, 9367), Rubicon (WB: MBL, PD027),
pSer172-TBK1 (IF: CST, 5483), a-Tubulin (WB: CST, 2144), UVRAG
(WB: MBL, M160-3B), WIPI2 (IF: Biorad, 2A2), Flag tag (WB and IF:
Sigma, F1804), S tag (WB and IF: Bethyl Labs, A190-135A), anti-
rabbit-HRP secondary (WB: CST, 7074), anti-mouse-HRP secondary
(WB: CST, 7076), anti-rabbit-Alexa 488 (IF: Invitrogen, A11008),
anti-rabbit-Alexa 594 (IF: Invitrogen, A11012), anti-mouse-Alexa 488
(IF: Invitrogen, A1101), anti-mouse-Alexa 594 (IF: Invitrogen,
A11032) and anti-mouse-Alexa 647 (IF: Invitrogen, A28181).
Fluorescence imaging
For immunofluorescence analyses, cells were grown on glass cover-
slips in a 6-well plate. Twenty-four hours later, cells were treated as
indicated. Coverslips were then fixed with 3.7% paraformaldehyde
(PFA) in 20 mM HEPES pH 7.5 for 10 min on ice and then 20 min
at RT. Cells were permeabilised in 0.1% Triton X-100 in PBS for
5 min at RT. Slides were then incubated in primary antibodies in
blocking buffer (1% BSA in PBS) at 37°C for 2–3 h or overnight at
4°C, followed by incubation with Alexa-conjugated secondary
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antibodies (Invitrogen) for 1 h at room temperature. Finally, nuclei
were stained with 1 lg/ml DAPI (Sigma) for 5 min at RT; then,
coverslips were mounted on microscope slides with Prolong Gold
Anti-fade (Invitrogen). Images were acquired using either the Leica
SP5 confocal microscope or, for super-resolution structured illumi-
nation microscopy (SIM), the Nikon N-SIM. SIM images were recon-
structed using the NIS Elements software.
Perinuclear EGFR localisation was assessed by staining endoge-
nous EGFR following stimulation with 2 ng/ml EGF. Analyses were
performed using ImageJ software by drawing circles around the
nucleus with a diameter of 30 lm, which was classed as “perinu-
clear”. The number of EGFR puncta inside or outside this region
was measured using the “Analyze particles” feature and a constant
threshold for each experiment.
For live cell imaging, cells were plated on glass-bottom plates
(World Precision Instruments, FluoroDish FD35-100) and starved of
serum for 4 h before the addition of Alexa 555-EGF (555-EGF, Invit-
rogen E35350). Live cell imaging was performed using the Andor
Dragonfly spinning disc confocal microscope. Vesicle tracking was
performed by Imaris Tracking software.
To assay EGF uptake, cells plated on either coverslips or in a 12-
well plastic-bottomed plate were stimulated with 20 ng/ml of
TxRed-EGF and 555-EGF, respectively. Cells were then fixed with
3.7% PFA and stained for DAPI. 555-EGF images were acquired
using the ImageXpress high-content plate reader, and TxRed-EGF
images were taken by confocal microscopy. To quantify these
images, a constant threshold was applied and the ImageJ “Analyze
particles” feature was used.
To assess the impact of autophagy loss on lysosomal acidifi-
cation, LysoSensor (Invitrogen, L7535) was added to cells at 1 lM
for 1 h before imaging unfixed cells using confocal microscopy and
a 20× objective. Total fluorescence levels were then analysed in
ImageJ and normalised to cell numbers followed by applying
“Analyze particles” feature.
Transferrin recycling was assayed by stimulating cells with
20 ng/ml Alexa 555-Transferrin (555-Tfn, Invitrogen, T35352) and
then chasing with Tfn-free, serum-free media to allow recycling of
the Tfn before fixing with 3.7% PFA and staining for Rab11.
For EGF/EGFR colocalisation, serum-starved cells were treated
for 4 h before stimulating with 20 ng/ml 555-EGF. Cells were then
stained for EGFR, and numbers of colocalised puncta were quanti-
fied manually in ImageJ. Total puncta numbers were determined
using a constant threshold on the “Analyze particles” feature.
The ImageJ “Coloc2” plugin was used to quantify Pearson’s colo-
calisation coefficients between: EGFR and EEA1, Rab4, Rab5, Rab7
or Rab11; EEA1 and PI(3)P; and 555-Tfn and Rab11. Alternatively,
the Imaris Coloc software was used to calculate the Pearson’s coeffi-
cient between 555-EGF and EEA1, Rab5 or Rab7.
For colocalisation between EEA1 and ATG16L1, WIPI2, FIP200,
Galectins, p-TBK1, GFP-LC3 or LAMP2 quantifications of colocalised
and total puncta numbers were conducted manually and using the
ImageJ “Analyze particles” feature with constant threshold,
respectively.
Post-fixation PI(3)P labelling
PI(3)P staining in cells was performed using a FYVE-Alexa 488
probe (kind gift from Ian Ganley, University of Dundee) as
previously described [44]. Briefly, cells plated on coverslips were
stimulated with 2 ng/ml EGF stimulation for 15 min. Treatment
with 10 lg/ml 3-methyladenine (3’MA, Sigma) for 1 h was used as
a negative control. Cells were washed with PBS and placed in gluta-
mate buffer (25 mM HEPES pH 7.4, 25 mM KCl, 2.5 mM MgAc,
5 mM EGTA, 150 mM potassium glutamate). Coverslips were then
briefly submerged in liquid nitrogen before thawing at RT and then
placed in glutamate buffer. Following washing with glutamate
buffer, cells were fixed with 3.7% PFA for 30 min followed by
quenching and incubation twice in DMEM with 10 mM HEPES pH
7.4 for 10 min. After blocking in 1% BSA in PBS, cells were
processed for immunostaining with the inclusion of FYVE-Alexa 488
(1:300) with the secondary antibody incubation.
Biotinylation endocytosis/recycling assay
Measurement of EGFR endocytosis and recycling was adapted from
previously described protocols (outlined in Fig EV4H [81,82]).
Briefly, serum-starved cells (4 h) were washed twice with ice-cold
PBS and labelled with 0.2 mg/ml biotin (EZ-Link sulfo-NHS-SS-
biotin, Thermo Fisher) for 30 min at 4°C. Excess sulfo-NHS-SS-
biotin was washed off with PBS and then quenched with 20 mM
glycine for 15 min at 4°C. EGFR endocytosis was induced by treat-
ment with 2 ng/ml EGF for 15 min at 37°C and then stopped with
ice-cold PBS washes. To strip biotin remaining on the cell surface, a
reduction reaction was performed using a buffer containing
37.5 mM NaOH, 37.5 mM NaCl, 25 mM L-glutathione, 25 mM
MesNA and 0.5% BSA for 30 min at 4°C, which was quenched with
20 mM iodoacetamide (Sigma) in PBS 20 min at 4°C. Receptor recy-
cling was then performed by incubating cells at 37°C in the presence
of EGF for a further 15 min. The stripping procedure was then
repeated. To isolate biotinylated proteins, cells were lysed in RIPA
buffer before or after the recycling step, and then incubated over-
night at 4°C with Streptavidin-sepharose high-performance beads
(GE Healthcare 17-5113-01). Beads were washed three times with
RIPA and then once with RIPA supplemented with 300 mM NaCl
final concentration, followed by two washes with PBS. Beads were
then analysed by SDS–PAGE and Western blotting.
EGF rescue of cell death assay
To investigate growth factor starvation-induced cell death, cells
were plated in a 12-well dish and serum starved in the presence or
absence of 20 ng/ml EGF. Twenty-four hours later, propidium
iodide (1 lg/ml, #10008351, Cayman) was added to cells and anal-
ysed using a Tecan Spark20M plate reader. Cells were then fixed
with 3.7% PFA and total cell number was obtained by staining with
DAPI and measurement using the Tecan plate reader. The ratio of
propidium iodide/DAPI relative fluorescence was then calculated to
obtain relative values of cell death. Representative cell images were
taken on a Leica DM IL LED microscope using Qimaging Retiga EXi
Fast1394.
Graphs and statistical analyses
All chart- and graph-making and statistical analyses were performed
using Microsoft Excel. A minimum of three independent experi-
ments were used in each analysis, and statistical significance was
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measured using an unpaired 2-sided Student’s t-test with signifi-
cance set at: NS P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001.
Expanded View for this article is available online.
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